Klebsiella pneumoniae related community-acquired acute lower respiratory infections in Cambodia: Clinical characteristics and treatment

BMC Infectious Diseases

Sirenda Vong¹  Bertrand Guillard¹  Philippe Buchy¹  Laurence Borand¹  Charles Mayaud³  Patrich Lorn Try²  Vantha Te⁴  Sopheak Hem¹  Julien Beauté¹  Sophie Goyet¹  Blandine Rammaert¹ 

[1] Institut Pasteur in Cambodia, Réseau International des Instituts Pasteur, Phnom Penh, Cambodia;Kampong Cham Provincial hospital, Kampong Cham, Cambodia;Centre de pneumologie et réanimation respiratoire, Hôpital Tenon, Paris, France;Donkeo Provincial Hospital, Takeo, Cambodia

关键词: Diabetes mellitus;    Extended-spectrum betalactamases;    Pneumonia;    Community-acquired;    Klebsiella pneumoniae;   

Others  :  1175487
DOI  :  10.1186/1471-2334-12-3

 received in 2011-07-22, accepted in 2012-01-10,  发布年份 2012

【 摘 要 】

Background

In many Asian countries, Klebsiella pneumoniae (KP) is the second pathogen responsible for community-acquired pneumonia. Yet, very little is known about KP etiology in ALRI in Cambodia, a country that has one of the weakest medical infrastructures in the region. We present here the first clinico-radiological description of KP community-acquired ALRI in hospitalized Cambodian patients.

Methods

Through ALRI surveillance in two provincial hospitals, KP was isolated from sputum and blood cultures, and identified by API20E gallery from patients ≥ 5 years-old with fever and respiratory symptoms onset ≤14 days. Antibiotics susceptibility testing was provided systematically to clinicians when bacteria were isolated. We collected patients' clinical, radiological and microbiological data and their outcome 3 months after discharge. We also compared KP-related with other bacteria-related ALRI to determine risk factors for KP infection.

Results

From April 2007 to December 2009, 2315 ALRI patients ≥ 5 years-old were enrolled including 587 whose bacterial etiology could be assigned. Of these, 47 (8.0%) had KP infection; their median age was 55 years and 68.1% were females. Reported prior medication was high (42.5%). Patients' chest radiographs showed pneumonia (61.3% including 39% that were necrotizing), preexisting parenchyma lesions (29.5%) and pleural effusions alone (4.5%) and normal parenchyma (4.5%). Five patients had severe conditions on admission and one patient died during hospitalization. Of the 39 patients that were hospital discharged, 14 died including 12 within 1 month after discharge. Only 13 patients (28%) received an appropriate antibiotherapy. Extended-spectrum beta-lactamases (ESBL) - producing strains were found in 8 (17.0%) patients. Female gender (Odds ratio (OR) 2.1; p = 0.04) and diabetes mellitus (OR 3.1; p = 0.03) were independent risk factors for KP-related ALRI.

Conclusions

KP ALRI in Cambodia has high fatality rate, are more frequently found in women, and should be considered in diabetic patients. The extremely high frequency of ESBL-producing strains in the study is alarming in the context of uncontrolled antibiotic consumption and in absence of microbiology capacity in most public-sector hospitals.

【 授权许可】

   
2011 Rammaert et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW: Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci 2006, 21(5):816-822.
• [2]Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, Génin R, Yvin JL: Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J 2004, 24(5):779-785.
• [3]Bansal S, Kashyap S, Pal LS, Goel A: Clinical and bacteriological profile of community acquired pneumonia in Shimla, Himachal Pradesh. Indian J Chest Dis Allied Sci 2004, 46(1):17-22.
• [4]Huang HH, Zhang YY, Xiu QY, Zhou X, Huang SG, Lu Q, Wang DM, Wang F: Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients. Eur J Clin Microbiol Infect Dis 2006, 25(6):369-374.
• [5]Reechaipichitkul W, Lulitanond V, Tantiwong P, Saelee R, Pisprasert V: Etiologies and treatment outcomes in patients hospitalized with community-acquired pneumonia (CAP) at Srinagarind Hospital, Khon Kaen, Thailand. Southeast Asian J Trop Med Public Health 2005, 36(1):156-161.
• [6]Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, McCormack JG, Yu VL: Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerging Infect Dis 2002, 8(2):160-166.
• [7]Radyowijati A, Haak H: Improving antibiotic use in low-income countries: an overview of evidence on determinants. Soc Sci Med 2003, 57(4):733-744.
• [8]Song JH, Oh WS, Kang CI, Chung DR, Peck KR, Ko KS, Yeom JS, Kim CK, Kim SW, Chang HH, Kim YS, Jung SI, Tong Z, Wang Q, Huang SG, Liu JW, Lalitha MK, Tan BH, Van PH, Carlos CC, So T, Asia Network for Surveillance of Resistant Pathogens Study Group: Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents 2008, 31(2):107-114.
• [9]Hawkey PM: Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 2008, 14(Suppl 1):159-165.
• [10]Turner PJ: Extended-spectrum beta-lactamases. Clin Infect Dis 2005, 41(Suppl 4):S273-S275.
• [11]Murray PR, Washington JA: Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1975, 50(6):339-344.
• [12]Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT: Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58(5):377-382.
• [13]American Diabetes Association: Postprandial blood glucose. Diabetes Care 2001, 24(4):775-778.
• [14]Franquet T: Imaging of pneumonia: trends and algorithms. Eur Respir J 2001, 18(1):196-208.
• [15]Grenier P: Image thoracique de l'adulte. Paris: Flammarion Médecine-Science; 1996.
• [16]Hsueh PR, Badal RE, Hawser SP, Hoban DJ, Bouchillon SK, Ni Y, Paterson DL, Asia-Pacific SMART Group: Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int J Antimicrob Agents 2010, 36(5):408-414. 2008
• [17]Gorman S, Pon D, Sok K: Gender and Development in Cambodia: An Overview. [http://www.cdri.org.kh/webdata/workpap/wp10-abs.htm] webcite
• [18]Mayor S: Better access to drugs in developing countries is accelerating resistance. BMJ 2010, 340:c3234.
• [19]Ruppé E, Hem S, Lath S, Gautier V, Ariey F, Sarthou JL, Monchy D, Arlet G: CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. Emerging Infect Dis 2009, 15(5):741-748.
• [20]Lin YT, Chen TL, Siu LK, Hsu SF, Fung CP: Clinical and microbiological characteristics of community-acquired thoracic empyema or complicated parapneumonic effusion caused by Klebsiella pneumoniae in Taiwan. Eur J Clin Microbiol Infect Dis 2010, 29(8):1003-1010.
• [21]Loh LC, Rosdara Masayuni MS, Nor Izran Hanim AS, Raman S, Thayaparan T, Kumar S: Adverse hospital outcomes associated with the choice of empiric antibiotics in Klebsiella pneumoniae pneumonia: a retrospective observational study. Ann Acad Med Singap 2007, 36(8):642-646.
• [22]Han XY, Tarrand JJ, Infante R, Jacobson KL, Truong M: Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol 2005, 43(9):4407-4412.
• [23]Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC: The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol 2007, 293(2):L272-L278.
• [24]Lee C, Liu J, Su L, Chien C, Li C, Yang K: Hypermucoviscosity associated with Klebsiella pneumoniae-mediated invasive syndrome: a prospective cross-sectional study in Taiwan. Int J Infect Dis 2010, 14(8):e688-e692.
• [25]Tsay RW, Siu LK, Fung CP, Chang FY: Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med 2002, 162(9):1021-1027.
• [26]Prince SE, Dominger KA, Cunha BA, Klein NC: Klebsiella pneumoniae pneumonia. Heart Lung 1997, 26(5):413-417.
• [27]Lin Y, Chen H, Liu Y, Shih C, Hsu W, Tu C: A 30-month experience of thoracic empyema in a tertiary hospital: emphasis on differing bacteriology and outcome between the medical intensive care unit (MICU) and medical ward. South Med J 2008, 101(5):484-489.
• [28]Tsang KY, Leung WS, Chan VL, Lin AWL, Chu CM: Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes. Hong Kong Med J 2007, 13(3):178-186.
• [29]Palwatwichai A, Chaoprasong C, Vattanathum A, Wongsa A, Jatakanon A: Clinical, laboratory findings and microbiologic characterization of bronchiectasis in Thai patients. Respirology 2002, 7(1):63-66.